Tower Research Capital LLC (Trc) Amphastar Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 797 shares of AMPH stock, worth $35,506. This represents 0.0% of its overall portfolio holdings.

Number of Shares

797

Previous 8,458 90.58%

Holding current value

$35,506

Previous $338,000 88.76%

% of portfolio

0.0%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$36.99 - $50.09 $283,380 - $383,739	-7,661 Reduced 90.58%	797 $38,000
Q2 2024 Aug 13, 2024	BUY	$38.65 - $43.48 $281,256 - $316,403	7,277 Added 616.17%	8,458 $338,000
Q1 2024 May 15, 2024	SELL	$42.85 - $63.45 $440,283 - $651,948	-10,275 Reduced 89.69%	1,181 $51,000
Q4 2023 Feb 13, 2024	BUY	$44.49 - $62.93 $457,846 - $647,612	10,291 Added 883.35%	11,456 $708,000
Q3 2023 Nov 14, 2023	BUY	$45.51 - $65.0 $1,046 - $1,495	23 Added 2.01%	1,165 $53,000
Q2 2023 Aug 14, 2023	SELL	$35.77 - $58.38 $30,619 - $49,973	-856 Reduced 42.84%	1,142 $65,000
Q1 2023 May 09, 2023	BUY	$27.99 - $37.92 $37,702 - $51,078	1,347 Added 206.91%	1,998 $75,000
Q4 2022 Feb 10, 2023	SELL	$27.93 - $31.27 $125,461 - $140,464	-4,492 Reduced 87.34%	651 $18,000
Q3 2022 Nov 10, 2022	BUY	$27.56 - $37.75 $83,892 - $114,911	3,044 Added 145.02%	5,143 $144,000
Q2 2022 Aug 15, 2022	SELL	$29.79 - $42.29 $243,801 - $346,101	-8,184 Reduced 79.59%	2,099 $73,000
Q1 2022 May 12, 2022	BUY	$22.96 - $36.45 $211,140 - $335,194	9,196 Added 846.0%	10,283 $370,000
Q4 2021 Feb 14, 2022	SELL	$18.14 - $23.29 $61,313 - $78,720	-3,380 Reduced 75.67%	1,087 $25,000
Q3 2021 Nov 15, 2021	BUY	$17.83 - $21.49 $39,315 - $47,385	2,205 Added 97.48%	4,467 $85,000
Q2 2021 Aug 16, 2021	SELL	$17.11 - $20.92 $821 - $1,004	-48 Reduced 2.08%	2,262 $46,000
Q1 2021 May 17, 2021	BUY	$17.21 - $20.65 $21,908 - $26,287	1,273 Added 122.76%	2,310 $42,000
Q4 2020 Feb 16, 2021	SELL	$17.76 - $21.24 $233,100 - $278,775	-13,125 Reduced 92.68%	1,037 $21,000
Q3 2020 Nov 16, 2020	BUY	$17.99 - $22.22 $184,091 - $227,377	10,233 Added 260.45%	14,162 $266,000
Q2 2020 Aug 13, 2020	BUY	$14.25 - $22.46 $55,988 - $88,245	3,929 New	3,929 $88,000
Q2 2019 Aug 13, 2019	SELL	$18.92 - $22.96 $9,554 - $11,594	-505 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$19.46 - $25.28 $9,827 - $12,766	505 New	505 $10,000
Q3 2018 Nov 13, 2018	SELL	$15.39 - $19.38 $40,660 - $51,201	-2,642 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$14.63 - $19.6 $234 - $313	-16 Reduced 0.6%	2,642 $40,000
Q1 2018 May 15, 2018	BUY	$17.23 - $20.35 $45,797 - $54,090	2,658 New	2,658 $50,000
Q4 2017 Feb 09, 2018	SELL	$17.76 - $19.75 $135,384 - $150,554	-7,623 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$14.73 - $17.99 $112,286 - $137,137	7,623	7,623 $136,000

Others Institutions Holding AMPH

# of Institutions

287

Shares Held

35.1M

Call Options Held

74.3K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.18B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Amphastar Pharmaceuticals, Inc. Transaction History